Jun 18, 2026 08:32AM
Jun 18, 2026 08:31AM
May 18, 2026 09:15AM
May 14, 2026 08:35AM
May 14, 2026 08:35AM
Feb 5, 2026 09:15AM
Feb 4, 2026 08:47AM GRI Bio raises $6.5 million, extends cash runway into Q1 2027
Feb 4, 2026 08:45AM
Jan 28, 2026 08:45AM
Jan 28, 2026 08:45AM
Jan 26, 2026 08:30AM
Jan 21, 2026 04:01PM
Jan 21, 2026 04:01PM
Jan 8, 2026 08:00AM GRI Bio reports positive immune profiling data from IPF drug trial
Jan 8, 2026 08:00AM
Dec 12, 2025 04:05PM
Dec 12, 2025 04:05PM
Dec 11, 2025 09:15AM
Dec 11, 2025 09:15AM
Dec 10, 2025 04:05PM
Dec 10, 2025 04:05PM GRI Bio Announces Positive Topline Data from its Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”) 
Sep 11, 2025 08:45AM
Sep 11, 2025 08:45AM
Jul 31, 2025 09:00AM
Jul 31, 2025 09:00AM
Jul 1, 2025 08:45AM
Jun 26, 2025 08:08AM
Jun 26, 2025 08:00AM GRI Bio’s GRI-0621 Demonstrates Encouraging Safety Results at Planned Interim 6-Week Analysis in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”)
May 22, 2025 08:03AM
May 22, 2025 08:00AM
May 15, 2025 08:35AM
May 15, 2025 08:35AM
May 8, 2025 08:48AM
May 8, 2025 08:45AM
May 7, 2025 09:15AM GRI Bio Continues to Drive Enrollment in Ongoing Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis (“IPF”)
Apr 16, 2025 08:35AM
Apr 2, 2025 04:05PM
Apr 1, 2025 11:15AM
Apr 1, 2025 11:15AM
Apr 1, 2025 09:00AM
Apr 1, 2025 09:00AM
Mar 31, 2025 08:03AM GRI Bio (GRI) Bolsters Intellectual Property Portfolio with Granting of Two Global Patents for Europe and Japan
Mar 31, 2025 08:00AM
Mar 18, 2025 09:05AM
Mar 17, 2025 08:05AM
Mar 11, 2025 08:35AM
Mar 11, 2025 08:35AM
Feb 19, 2025 04:05PM
Feb 19, 2025 04:05PM GRI Bio Announces Reverse Stock Split
Feb 19, 2025 09:00AM

1,160,150 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All